PRECOS Appoints Dr. Neil Rotherham as Chairman

06-Oct-2010 - United Kingdom

Preclinical oncology services Limited (PRECOS) announced the appointment of Dr. Neil Rotherham as chairman of the PRECOS board. Dr. Rotherham has over 20 years' leadership experience in the Life Sciences, medical, pharmaceutical and biopharmaceutical sectors. His extensive business experience and industry knowledge will be invaluable in the development and growth of the company going forward.

Dr. Rotherham was responsible for developing and growing ClinPhone plc, one of Nottingham's and Europe's most successful clinical technology businesses. As co-founder and managing director of ClinPhone, Dr. Rotherham led the company from a two-person start-up in 1993 to a 500-person global venture that was listed on the London Stock Exchange in 2006. Dr. Rotherham left the business after bringing through a management team to run the business subsequent to going public.

Prior to co-founding ClinPhone, Dr. Rotherham worked in the pharmaceutical industry on medicine development for Boots Pharmaceuticals. His prior qualification in medicine and training as a hospital physician will undoubtedly be beneficial to PRECOS as it looks to establish its range of innovative services within the global healthcare industry. Dr. Rotherham brings a wealth of experience in growing businesses providing services to drug development companies.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances